Home
Our Business
About
Mission & Heritage
Values
Management
Facilities
News & Announcements
Innovation
Analytical
Generic Research
Intellectual Property
New Drug Discovery
Opportunities
Markets
India
International
Investors
Financials
financials
Subsidiary Accounts
Share Monitor
Shareholder Information
Shareholding Pattern
Investor Service Request Form
Investor Presentation
Statutory Communications
Scheme of Amalgamation
Unclaimed Dividend
Investors Education Protection Fund (IEPF)
Buy back
Buy back 2018
Buy back 2023
PAPER ADVERTISEMENTS
Board Meeting Intimations
ANNUAL SECRETARIAL COMPLIANCE CERTIFICATE
CREDIT RATINGS
Annual Reports
Annual Return
AGM
Impact Assessment Report
Corporate Governance & Policies
Corporate Governance Certificate
IR AND SHAREHOLDER CONTACTS
INVESTOR RELATIONS
FOR GRIEVANCE REDRESSAL
QIP 2017
People
Meet Our People
Careers
Responsibility
CSR Policy
Environment, Health & Safety
Attivaram
Chemical unit-Mekaguda
Chemical Unit-Chennai
Certification & Awards
Natco Trust
Business Responsibility Policies
Sustainability Report
ESG PROFILE
Contact
Locations
Contact us
Our growth story has only just begun. We endeavour to mitigate risk for investors and encourage transparency in all our dealings
Scheme of Amalgamation - Natco Pharma
High Court Order - April 2016
Resolutions
Scheme of Amalgamation
Valuation Report
Report from the Audit Committee
Fairness Opinion
Shareholding Pattern
Networth Certificate
Auditor Certificate for Accounting Treatment
Corporate Governance Report
Audited Financials
Compliance Report
Complaints Report
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
Privacy policy
